EquityBulls

Latest News

Glenmark Pharma arm receives upfront payment of $700 Mn from AbbVie
Embassy Developments' New Project 'Paradiso' in North Bengaluru Fully Sold Out with Topline of ~₹204 Cr
Bartronics India Ltd enters into MoU with RenewCred
RailTel Corporation of India Ltd receives LOA worth Rs. 262.14 crore
Arisinfra and Vaishnavi Residences Launch Arsh Greens, a community of Exclusive Villa Plots "within" the City of Bengaluru

Keywords Selected: USFDA

Stock Report

USFDA conducts product specific pre-approval inspection at Lupin Ltd's Aurangabad facility
Closure of USFDA inspection at Zydus' injectable manufacturing plant at Jarod
U.S. FDA Completes Inspection at Biocon Biologics' Facility at Biocon Campus, Bengaluru, India
Caplin Steriles Ltd granted final approval for ANDA Milrinone Lactate in 5% Dextrose Injection by USFDA
Lupin receives U.S. FDA approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity
Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
SMS Pharmaceuticals Ltd receives EIR from USFDA for Central Laboratory Analytical Services
Unichem Laboratories Ltd receives EIR from USFDA classifying Roha API facility as VAI
Gland Pharma receives approval for Vasopressin in 5% Dextrose RTU Injection
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg
Gland Pharma receives approval for Norepinephrine Bitartrate in 5% Dextrose Injection Bags
Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial
Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Senores Pharmaceuticals Ltd's material subsidiary reeceives 3 observations from USFDA for its facility
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg
Lupin receives US FDA Approvals for Liraglutide and Glucagon Injectable Products
Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
Lupin receives Form 483 with 3 observations from USFDA for Pithampur Unit-3
Lupin receives Form 483 with 4 observations from USFDA for Pithampur Unit-2
EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg
Emcure Pharmaceuticals Ltd successfully completes USFDA PAI of Oncology facility